Advertisement

Cardiology

Home Cardiology
Allopurinol dose escalation is not associated with reductions in mortality risk among patients with gout

Allopurinol Dose Escalation for Gout Doesn’t Improve Mortality

Linked to small increase in mortality; at 2 years, 31 percent of dose escalators achieved serum urate goal
Almost 20 percent of children and adolescents used prescription medications in 2013 to 2014

20% of Children, Adolescents Use Prescription Medications

8.2 percent of concurrent users of prescription meds at risk for potentially major drug-drug interactions
The most common electronically sent and received types of patient health information include laboratory results and medication lists

Patient Health Information Often Shared Electronically

Most commonly observed types of PHI sent are referrals, laboratory results, medication lists
The U.S. Environmental Protection Agency has formally released its proposal to replace the Clean Power Plan with the Affordable Clean Energy Rule

EPA Plan Will Maintain Carbon Emissions From Power Plants

Inadequate regulation of carbon pollution will likely have current, future consequences for human health
A cardiac magnetic resonance with contrast protocol is feasible for implementation in the developing world and can impact management

Cardiac MR With Contrast Feasible in Developing World

Cardiac magnetic resonance has cost of $150 and average scan duration of 18 ± 7 minutes
Fourteen percent of older adults hospitalized with non-cardiac conditions are discharged with intensified antihypertensive treatment

HTN Tx Intensification Common Upon Discharge in U.S. Vets

Fourteen percent of older adults admitted to hospital for non-cardiac conditions had intensification of tx
In 2016 the age-standardized prevalence of insufficient physical activity was 27.5 percent

Global Prevalence of Insufficient Activity 27.5 Percent

Levels of insufficient physical activity stable between 2001, 2016; increase seen in high-income countries
Rivaroxaban does not lower risk of symptomatic venous thromboembolism and related death in medical patients after hospital discharge

No Clear Benefit for Rivaroxaban After Hospital Discharge

Incidence of major bleeding low with rivaroxaban, but clot risk not lower
Half of trials on the European Union Clinical Trials Register are non-compliant with the European Commission's requirement that all trials post results to the registry within 12 month of completion

Compliance With Requirement to Report Results on EUCTR Is Poor

Half of trials on European Union Clinical Trials Register are non-compliant with requirements
Prices for drugs under shortage increase more than twice as quickly as expected in the absence of a shortage

Drug Prices Increase More Than Expected After Shortages

Expected price increase 20 percent for all drugs after shortage versus 9 percent in absence of shortage